Correlation Between Snap and SCI Pharmtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Snap and SCI Pharmtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Snap and SCI Pharmtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Snap Inc and SCI Pharmtech, you can compare the effects of market volatilities on Snap and SCI Pharmtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Snap with a short position of SCI Pharmtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Snap and SCI Pharmtech.

Diversification Opportunities for Snap and SCI Pharmtech

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Snap and SCI is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Snap Inc and SCI Pharmtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCI Pharmtech and Snap is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Snap Inc are associated (or correlated) with SCI Pharmtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCI Pharmtech has no effect on the direction of Snap i.e., Snap and SCI Pharmtech go up and down completely randomly.

Pair Corralation between Snap and SCI Pharmtech

Given the investment horizon of 90 days Snap Inc is expected to generate 4.23 times more return on investment than SCI Pharmtech. However, Snap is 4.23 times more volatile than SCI Pharmtech. It trades about 0.07 of its potential returns per unit of risk. SCI Pharmtech is currently generating about 0.17 per unit of risk. If you would invest  1,070  in Snap Inc on August 29, 2024 and sell it today you would earn a total of  90.00  from holding Snap Inc or generate 8.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Snap Inc  vs.  SCI Pharmtech

 Performance 
       Timeline  
Snap Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Snap Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively sluggish basic indicators, Snap reported solid returns over the last few months and may actually be approaching a breakup point.
SCI Pharmtech 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in SCI Pharmtech are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, SCI Pharmtech may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Snap and SCI Pharmtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Snap and SCI Pharmtech

The main advantage of trading using opposite Snap and SCI Pharmtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Snap position performs unexpectedly, SCI Pharmtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCI Pharmtech will offset losses from the drop in SCI Pharmtech's long position.
The idea behind Snap Inc and SCI Pharmtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance